1. Home
  2. MIST vs CFBK Comparison

MIST vs CFBK Comparison

Compare MIST & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • CFBK
  • Stock Information
  • Founded
  • MIST 2003
  • CFBK 1892
  • Country
  • MIST Canada
  • CFBK United States
  • Employees
  • MIST N/A
  • CFBK N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • CFBK Major Banks
  • Sector
  • MIST Health Care
  • CFBK Finance
  • Exchange
  • MIST Nasdaq
  • CFBK Nasdaq
  • Market Cap
  • MIST 132.5M
  • CFBK 154.3M
  • IPO Year
  • MIST N/A
  • CFBK 1998
  • Fundamental
  • Price
  • MIST $1.43
  • CFBK $23.50
  • Analyst Decision
  • MIST Strong Buy
  • CFBK Buy
  • Analyst Count
  • MIST 2
  • CFBK 1
  • Target Price
  • MIST $7.50
  • CFBK $29.00
  • AVG Volume (30 Days)
  • MIST 2.9M
  • CFBK 17.6K
  • Earning Date
  • MIST 08-15-2025
  • CFBK 08-04-2025
  • Dividend Yield
  • MIST N/A
  • CFBK 1.36%
  • EPS Growth
  • MIST N/A
  • CFBK N/A
  • EPS
  • MIST N/A
  • CFBK 2.28
  • Revenue
  • MIST N/A
  • CFBK $47,663,000.00
  • Revenue This Year
  • MIST N/A
  • CFBK $35.39
  • Revenue Next Year
  • MIST N/A
  • CFBK $10.11
  • P/E Ratio
  • MIST N/A
  • CFBK $10.30
  • Revenue Growth
  • MIST N/A
  • CFBK 1.22
  • 52 Week Low
  • MIST $0.63
  • CFBK $19.23
  • 52 Week High
  • MIST $2.75
  • CFBK $31.17
  • Technical
  • Relative Strength Index (RSI)
  • MIST 40.51
  • CFBK 39.21
  • Support Level
  • MIST $1.42
  • CFBK $23.26
  • Resistance Level
  • MIST $1.64
  • CFBK $23.89
  • Average True Range (ATR)
  • MIST 0.11
  • CFBK 0.32
  • MACD
  • MIST -0.03
  • CFBK -0.06
  • Stochastic Oscillator
  • MIST 8.95
  • CFBK 21.43

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: